{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:51:33Z","timestamp":1782186693815,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s10620-011-1661-7","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T20:27:55Z","timestamp":1301084875000},"page":"2750-2757","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic Factors and Survival Analysis of Antimitochondrial Antibody-Positive Primary Biliary Cirrhosis in Chinese Patients"],"prefix":"10.1007","volume":"56","author":[{"given":"Dan-Tong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"key":"1661_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. American association for study of liver diseases. Primary biliary cirrhosis. Hepatology. 2009;50:291\u2013308.","journal-title":"Hepatology"},{"key":"1661_CR2","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","volume":"138","author":"ME Gershwin","year":"1987","unstructured":"Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70\u00a0kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987;138:3525\u20133531.","journal-title":"J Immunol"},{"key":"1661_CR3","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1572-0241.2005.50007.x","volume":"100","author":"GL Wong","year":"2005","unstructured":"Wong GL, Hui AY, Wong VW, Chan FK, Sung JJ, Chan HL. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am J Gastroenterol. 2005;100:2205\u20132211.","journal-title":"Am J Gastroenterol"},{"key":"1661_CR4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1478-3231.2008.01715.x","volume":"28","author":"CW Su","year":"2008","unstructured":"Su CW, Hung HH, Huo TI, et al. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: A follow-up study up to 18\u00a0years. Liver Int. 2008;28:1305\u20131313.","journal-title":"Liver Int"},{"key":"1661_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1440-1746.2007.05058.x","volume":"23","author":"RK Wong","year":"2008","unstructured":"Wong RK, Lim SG, Wee A, Chan YH, Aung MO, Wai CT. Primary biliary cirrhosis in Singapore: Evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol. 2008;23:599\u2013605.","journal-title":"J Gastroenterol Hepatol"},{"key":"1661_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology. 1989;10:1\u20137.","journal-title":"Hepatology"},{"key":"1661_CR7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","volume":"123","author":"M Prince","year":"2002","unstructured":"Prince M, Chetwynd A, Newman W, Metcalf JV, James OF. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28\u00a0years. Gastroenterology. 2002;123:1044\u20131051.","journal-title":"Gastroenterology"},{"key":"1661_CR8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s A, Caballer\u00eda L, Rod\u00e9s J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;130:715\u2013720.","journal-title":"Gastroenterology"},{"key":"1661_CR9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.21759","volume":"46","author":"MG Peters","year":"2007","unstructured":"Peters MG, Di Bisceglie AM, Kowdley KV, et al. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology. 2007;46:769\u2013775.","journal-title":"Hepatology"},{"key":"1661_CR10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhep.2004.06.005","volume":"41","author":"E Christensen","year":"2004","unstructured":"Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores\u2014Where are we and where should we go? J Hepatol. 2004;41:344\u2013350.","journal-title":"J Hepatol"},{"key":"1661_CR11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","volume":"51","author":"European Association for the Study of the Liver","year":"2009","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: Management of cholestatic liver diseases. J Hepatol. 2009;51:237\u2013267.","journal-title":"J Hepatol"},{"key":"1661_CR12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","volume":"25","author":"P Invernizzi","year":"1997","unstructured":"Invernizzi P, Crosignani A, Battezzati PM, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology. 1997;25:1090\u20131095.","journal-title":"Hepatology"},{"key":"1661_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978;379:103\u2013112.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"1661_CR14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/jhep.2003.50093","volume":"37","author":"RF Vel\u00e1zquez","year":"2003","unstructured":"Vel\u00e1zquez RF, Rodr\u00edguez M, Navascu\u00e9s CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37:520\u2013527.","journal-title":"Hepatology"},{"key":"1661_CR15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187\u2013220.","journal-title":"J R Stat Soc B"},{"key":"1661_CR16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","volume":"28","author":"B Liu","year":"2008","unstructured":"Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Antimitochondrial antibody-negative primary biliary cirrhosis: A subset of primary biliary cirrhosis. Liver Int. 2008;28:233\u2013239.","journal-title":"Liver Int"},{"key":"1661_CR17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/MEG.0b013e3281ace0b7","volume":"19","author":"KT Fung","year":"2007","unstructured":"Fung KT, Fung J, Lai CL, Yuen MF. Etiologies of chronic liver diseases in Hong Kong. Eur J Gastroenterol Hepatol. 2007;19:659\u2013664.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1661_CR18","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","volume":"119","author":"WR Kim","year":"2000","unstructured":"Kim WR, Lindor KD, Locke GR 3rd, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000;119:1631\u20131636.","journal-title":"Gastroenterology"},{"key":"1661_CR19","first-page":"12","volume":"13","author":"HP Yan","year":"2005","unstructured":"Yan HP, Zhuang H, Liu YM, et al. Immunological characteristics of primary biliary cirrhosis patients. Zhonghua Gan Zang Bing Za Zhi. 2005;13:12\u201316.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1661_CR20","first-page":"861","volume":"17","author":"EL Gu","year":"2009","unstructured":"Gu EL, Yao GB. The clinical characteristics of primary biliary cirrhosis in China: a systematic review. Zhonghua Gan Zang Bing Za Zhi. 2009;17:861\u2013866.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"1661_CR21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-230X-10-100","volume":"10","author":"H Liu","year":"2010","unstructured":"Liu H, Liu Y, Wang L, et al. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in South China. BMC Gastroenterol. 2010;10:100.","journal-title":"BMC Gastroenterol"},{"key":"1661_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-59745-518-3_19","volume-title":"Liver immunology: Principles and practice","author":"C Selmi","year":"2007","unstructured":"Selmi C, Lleo A, Invernizzi P, Gershwin ME. Part III: Autoimmune liver diseases. Chapter 18: Primary biliary cirrhosis and autoimmune cholangitis. In: Gershwin ME, Jone MV, Michael PM, eds. Liver immunology: Principles and practice. Totowa, New Jersey: Humana; 2007:235\u2013247."},{"key":"1661_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0676.1995.tb00110.x","volume":"15","author":"K Inoue","year":"1995","unstructured":"Inoue K, Hirohara J, Nakano T, et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver. 1995;15:70\u201377.","journal-title":"Liver"},{"key":"1661_CR24","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261\u20131273.","journal-title":"N Engl J Med"},{"key":"1661_CR25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","volume":"53","author":"MI Prince","year":"2004","unstructured":"Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut. 2004;53:865\u2013870.","journal-title":"Gut"},{"key":"1661_CR26","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","volume":"42","author":"ME Gershwin","year":"2005","unstructured":"Gershwin ME, Selmi C, Worman HJ, et al. Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients. Hepatology. 2005;42:1194\u20131202.","journal-title":"Hepatology"},{"key":"1661_CR27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090\u20131101.","journal-title":"N Engl J Med"},{"key":"1661_CR28","first-page":"87","volume":"14","author":"T Hano","year":"1968","unstructured":"Hano T. Pathohistological study on liver cirrhosis in diabetes mellitus. Kobe J Med Sci. 1968;14:87\u2013106.","journal-title":"Kobe J Med Sci"},{"key":"1661_CR29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1155\/1999\/810264","volume":"13","author":"MR Borgaonkar","year":"1999","unstructured":"Borgaonkar MR, Morgan DG. Primary biliary cirrhosis and type II autoimmune polyglandular syndrome. Can J Gastroenterol. 1999;13:767\u2013770.","journal-title":"Can J Gastroenterol"},{"key":"1661_CR30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","volume":"25","author":"P Invernizzi","year":"2005","unstructured":"Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis. 2005;25:298\u2013310.","journal-title":"Semin Liver Dis"},{"key":"1661_CR31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","volume":"42","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Shimizu-Yoshida Y, Takii Y, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol. 2005;42:386\u2013392.","journal-title":"J Hepatol"},{"key":"1661_CR32","doi-asserted-by":"crossref","first-page":"s412","DOI":"10.1111\/j.1872-034X.2007.00244.x","volume":"37","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Komori A, Ito M, et al. Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosis. Hepatol Res. 2007;37:s412\u2013s419.","journal-title":"Hepatol Res"},{"key":"1661_CR33","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1111\/j.1872-034X.2007.00227.x","volume":"37","author":"HJ Worman","year":"2007","unstructured":"Worman HJ. Nuclear envelope protein autoantigens in primary biliary cirrhosis. Hepatol Res. 2007;37:S406\u2013S411.","journal-title":"Hepatol Res"},{"key":"1661_CR34","first-page":"655","volume":"26","author":"XF Liang","year":"2005","unstructured":"Liang XF, Chen YS, Wang XJ, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:655\u2013658.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"1661_CR35","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmunehepatitis overlap syndrome: Clinical features and response to therapy. Hepatology. 1998;28:296\u2013301.","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-1661-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1661-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:04:01Z","timestamp":1741111441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1661-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1661"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1661-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,16]]}}}